E. Direct, Medical Follow-Up Costs for Patients The Senegalese Antiretroviral Drug Access Initiative. An Economic Social Behavioural and Biomedical Analysis, pp.49-59, 2004.

A. Desclaux, Equity in access to aids treatment in Africa : pitfalls among achievements, in Unhealthy Health initiatives : a critical anthropological examination, 2004.
DOI : 10.1522/030162308

M. Egrot, B. Taverne, M. Ciss, I. Ndoye, A. Epelboin et al., Antiretroviral drugs in the informal medicine trade in West Africa: The situation in Senegal [abstract TuPeE5143, Proceedings of the 14th International AIDS conference, pp.7-12, 2002.

W. Holmes, 3 by 5, but at what cost?, The Lancet, vol.363, issue.9414, pp.1072-1073, 2004.
DOI : 10.1016/S0140-6736(04)15847-9

E. Katabira, Les traitement antirétroviraux en Ouganda, in World Health Organization, Les incidences des traitements antirétroviraux: Consultation informelle, pp.119-124, 1997.

I. Ndoye, Adherence to HAART and Its Principal Determinants in a Cohort of Senegalese Adults, Aids, vol.17, issue.3, pp.103-108, 2003.

J. Mukherjee, Basing treatment on rights rather than ability to pay: 3 by 5, The Lancet, vol.363, issue.9414, pp.1071-1072, 2004.
DOI : 10.1016/S0140-6736(04)15846-7

C. Norman, Using social health insurance to meet policy goals, Soc. Sci. Med, vol.48, pp.865-874, 1999.

O. Lusaka, Emergency scale up of antiretroviral therapy in resource limited settings : technical and operational recommendations to achieve three by five, rapport de la réunion, pp.18-21, 2003.

R. Vuarin, Un système africain de protection sociale au temps de la mondialisation ou « Venez m'aider à tuer mon lion?, Coll. Villes et Entreprises, l'Harmattan, 2000.

B. Zaba, A. Whiteside, and J. T. Boerma, Demographic and socioeconomic impact of AIDS, AIDS, vol.18, issue.Supplement 2, pp.1-7, 2004.
DOI : 10.1097/00002030-200406002-00001